Table 1.
Study | Test Model | Nociceptive State | Vehicle | Specie Sex (M/F) | Effect of APAP | PO mg/kg | IP/SC/IPLT mg/kg | IV mg/kg | IT µg | ICV µg | Reference | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | Ginger rhizome enhances anti-inflammatory and anti-nociceptive effects of APAP in mouse fibromyalgia | Paw pressure Hot plate Tail flick | Fibromyalgia syndrome | Saline | Mice/F | Increased threshold | 400 | Montserrat-de la Paz et al 201866 | ||||
2. | Enhanced analgesic effects of nefopam with APAP | Tail flick Hot plate | Normal | Saline | Mice/F, M | No change | 42–168 | Li et al 2018107 | ||||
Tail flick Hot plate | Normal | Saline | Mice/F, M | No change | 60–240 | |||||||
3. | Central dopaminergic system plays a role in analgesic action of APAP | Hot plate | Normal | Saline | Mice/M | Increased escape latency | 100 | Bhagyashree et al 201868 | ||||
4. | Effect of modulating 5-HT on analgesic action of APAP | Hot plate | Normal | N/A | Albino mice/F, M | Increased latency | 200 | Karandikar et al 2016110 | ||||
5. | Interactions with codeine and APAP in mice | Hot plate | Normal mice | Saline | Mice/F, M | Increased latency | 20 | Raskovic et al 2015111 | ||||
6. | Synergic effects of pregabalin–APAP combination in somatic and visceral nociceptive reactivity | Tail flick | Normal mice | Saline | Mice/M | Increased latency | 200 | Mititelu et al 2014101 | ||||
7. | APAP administration during neonatal brain development affects cognitive function and alters analgesic and anxiolytic response in adult | Hot plate | Normal mice | Saline | Mice/M | Increased latency | 30–60 | Viberg et al 201491 | ||||
8. | Cav3.2 calcium channels in supraspinal effect of APAP | Tail flick Von Frey Paw immersion tests | Normal mice or Cav3.2 knockout mice | Saline | Mice/M | Increased latency | 200 | Kerckhove et al 201470 | ||||
9. | TRPA1 mediates spinal antinociception induced by APAP and a cannabinoid. | Hot plate Paw pressure | Normal mice or Trpa1–/– mice | Saline | Mice/M | Effects of spinal/systemic APAP lost in Trpa1–/– | 300 | Andersson et al 2011141 | ||||
Hot plate Paw pressure | Normal mice or Trpa1–/– mice | Saline | Mice/M | Effects of spinal/systemic APAP lost in Trpa1–/– | 50 or 100 | |||||||
10 | Phenazopyridine on rat bladder primary afferent activity, and comparison with lidocaine and APAP | Bladder primary afferent activity | Normal | Saline | Rat/F | Decreased activity | 1–10 | Aizawa et al 201092 | ||||
11 | Different mechanisms underlie analgesic actions of APAP and dipyrone in inflammatory pain | Von Frey | Normal | Saline | Rat/M | Increased threshold Dose dependent |
60–360 | Rezende et al 2008124 | ||||
12. | Endocannabinoid and serotonergic systems needed for APAP-induced analgesia | Von Frey Hot plate | Normal | DMSO and saline | Rat/M | Increased threshold | 300 | Mallet et al 200895 | ||||
13. | Differential involvement of opioid and 5-HT systems in the antinociceptive activity of AM404: comparison with APAP | Hot plate Paw pressure | Normal | 12.5% 1,2-propanediol and saline | Rat/M | Increased threshold | 400 | Ruggieri et al 200876 | ||||
14. | Effect of acute and repeated administration of APAP on opioid and 5-HT systems | Hot plate | Normal | Saline | Rat/M | Increased threshold | 400 | Sandrini et al 2007139 | ||||
15. | Modulation of APAP by caffeine and by adenosine A2 receptor antagonists.- | Von Frey Hot plate | Normal | PO4 buffer saline | Mice/N/A | Increased threshold | 10–200 | Godfrey et al 2006116 | ||||
16. | The analgesic activity of APAP is prevented by CB1 receptor blockade | Hot plate | Normal | Saline | Rat/M | Increased threshold Dose dependent |
250–1000 | Ottani et al 200677 | ||||
17. | Opioid receptor antagonists on action of APAP | Paw pressure | Normal | Saline | Rat/M | Increased threshold | 400 | Bujalska 200481 | ||||
18. | APAP involves spinal tropisetron-sensitive, non–5-HT3 receptor | Paw pressure | Normal | Saline | Rat/M | Increased threshold | 400 | Libert et al 2004173 | ||||
19. | Involvement of central 5-HT1B and 5-HT3 receptors in effect of APAP | Hot plate Paw pressure | Normal | 1,2-propanediol/saline | Rat/M | Increased latency/threshold |
400 | Sandrini et al 2003117 | ||||
20. | Role of 5-HT1A/B autoreceptors in antinociceptive effect of APAP | Hot plate | Normal | Propylene glycol/water | Mice/M | Increased latency Dose dependent |
300–800 | Roca-Vinardell et al 2003140 | ||||
21. | NCX-701 (nitroAPAP) is an effective antinociceptive agent in rat withdrawal reflexes and wind-up | Electrical stimulation Von Frey | Normal | DMSO/polyethylene glycol | Rat/M | Increased threshold | 22–724 | Romero-Sandoval et al 2002150 | ||||
22. | COX and NOS inhibitors on action of APAP | Paw pressure | Normal | Saline | Rat/M | Increased threshold Dose dependent |
100–800 | Bujalska and Gumulka 200184 | ||||
23. | 5-HT receptor subtypes involved in spinal antinociceptive effect of APAP | Paw pressure test | Normal | Trisodic citrate, 0.02 g/mL | Rat/M | Increased threshold | 200 | Courade et al 2001151 | ||||
24. | APAP-induced antinociception via central 5-HT2A receptors | Tail flick | Normal rat | 12.5% of 1,2-propanediol in saline | Rat/M | Increased latency | 300 or 400 | Srikiatkhachorn et al 1999127 | ||||
25. | APAP exerts spinal antinociceptive effect involving interaction with 5-HT3 receptors | Paw pressure | Normal | Solvent trisodic citrate, 0.02 g/mL | Rat/M | Increased threshold | 200–800 | Pelissier et al 199687 | ||||
Paw pressure | Normal | Solvent trisodic citrate, 0.02 g/mL | Rat/M | Increased threshold | 50–300 | |||||||
Paw pressure | Normal | Solvent trisodic citrate, 0.02 g/mL | Rat/M | Increased threshold | 100–200 | |||||||
26. | Antinociceptive action of APAP associated with changes in 5-HT system in brain | Hot plate | Normal | 1,2-propanediol in saline | Rat/M | Increased latency Dose dependent |
200–400 | Pini et al 1996128 | ||||
27. | Central APAP effect involving spinal 5-HT3 receptors | C fiber-evoked reflex | Normal | N/A | Rat/M | Increased threshold | 200–400 | Pelissier et al 1995153 | ||||
28. | Increasing-temperature hot plate test | Hot plate | Normal | Propanediol in NaCl | Rat or mice/M | Increased latency | 200–400 | Tjølsen et al 1990119 | ||||
29. | Depression by morphine, metamizol (dipyrone), lysine acetylsalicylate and APAP, of thalamus neurons evoked by electrical stimulation | Behavioral response and evoked activity in thalamus | Normal | Saline | Rat/M | Increased threshold Dose dependent |
5–25 | Carlsson et al 1988174 | ||||
30. | Central effect of APAP depresses nociceptive activity in thalamic neurons | Behavioral response | Normal | Saline | Rat/M and F | Increased threshold | 50–150 | Carlsson and Jurna 1987134 | ||||
31. | Acute toxicity and analgesic action of a combination of buclizine, codeine and APAP in tablet/suppository form | Tail flick | Normal | Saline | Mice/M and F | Increased latency Dose dependent |
97–772 | Behrendt et al 198598 | ||||
32. | Blood levels and analgesic effects of APAP | Paw pressure | Normal | Water | Mice/M | Increased threshold Dose dependent |
149–360 | Shibasaki et al 1979152 | ||||
Paw pressure | Normal | Water | Mice/M | Increased threshold Dose dependent |
111–360 | |||||||
33. | Inhibition of prostaglandin synthetase in the brain by APAP | N/R | N/R | N/R | Rabbit/NR | Increased threshold | ID50 14 μg/mL | Flower and Vane 1972105 |